TNF/lymphotoxin-α double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 5937-5942

  Hultgren, Olof ^a   Eugster, Hans Pietro ^b   Sedgwick, Jonathon D ^c   Körner, Heinrich ^d   Tarkowski, Andrzej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c CENTENARY INSTITUTE   (Australia)

^d Inst Neurobio Hyg and Immunol   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EROSION; HISTOPATHOLOGY; IMMUNE RESPONSE; MALE; MORTALITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN CELL; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; SYNOVITIS; TOXIC SHOCK SYNDROME;

ANIMALS; ANTIBODY SPECIFICITY; ARTHRITIS, INFECTIOUS; B-LYMPHOCYTES; DOWN-REGULATION; EPITOPES, B-LYMPHOCYTE; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOTOXIN-ALPHA; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NZB; MICE, KNOCKOUT; PHAGOCYTOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032400982     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Esterhai, J. L., and I. Gelb. 1991. Adult septic arthritis. Orthop. Clin. North Am. 22:503.
2. Meijers, K. A. E., B. A. C. Dijkmans, J. Hermans, P. J. van den Broek, and A. Cats. 1987. Non-gonococcal infectious arthritis: a retrospective study. J. Infection 14:13.
3. Goldenberg, D. L. 1989. Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum. 32:496.
4. Goldenberg, D. L. 1992. Septic arthritis in chronic joint disease. Rheumatol. Rev. 4:147.
5. Sakiniene, E., T. Bremell, and A. Tarkowski. 1996. Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis. Arthritis Rheum. 39:1596.
6. Bremell, T., S. Lange, L. Svensson, E. Jennische, K. Gröndahl, H. Carlsten, and A. Tarkowski. 1990. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum. 33:1739.
7. Abdelnour, A., T. Bremell, R. Holmdahl, and A. Tarkowski. 1994. Role of T lymphocytes in experimental Staphylococcus aureus. Scand. J. Immunol. 39:403.
8. Abdelnour, A., T. Bremell, R. Holmdahl, and A. Tarkowski. 1994. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur. J. Immunol. 24: 1161.
9. Abdelnour, A., T. Bremell, and A. Tarkowski. 1994. Toxic shock syndrome toxin-1 contributes to the arthritogenicity of Staphylococcus aureus. J. Infect. Dis. 170:84.
10. Zhao, Y.-X., A. Abdelnour, R. Holmdahl, and A. Tarkowski. 1995. Mice with the xid B cell defect are less susceptible to developing Staphylococcus aureus-induced arthritis. J. Immunol. 155:2067.
11. Zhao, Y.-X., Å. Ljungdahl, T. Olsson, and A. Tarkowski. 1996. In situ hybridization analysis of synovial and systemic cytokine messenger RNA expression in superantigen-mediated Staphylococcus aureus arthritis. Arthritis Rheum. 39:959.
12. Rothe, J., W. Lesslauer, H. Lötscher, Y. Lang, P. Koebel, F. Köntgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
13. Tite, J. P., G. Dougan, and S. N. Chatfield. 1991. The involvement of tumor necrosis factor in immunity to Salmonella infection. J. Immunol. 147:3161.
14. Takashima, K., K. Teateda, T. Matsumoto, Y. Iizawa, M. Nakao, and K. Yamagucho. 1997. Role of tumor necrosis factor α in pathogenesis of pneumococcal pneumonia in mice. Infect. Immun. 65:257.
15. Hinshaw, L. B., T. E. Emerson, F. B. Taylor, A. C. Chang, M. Duerr, G. T. Peer, D. J. Flourney, G. L. White, S. D. Kosanke, and C. K. Murray. 1992. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J. Trauma 33:568.
16. Freudenberg, M. A., and C. Galanos. 1991. Tumor necrosis factor α mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59:2110.
17. Tak, P. P., P. C. Taylor, F. C. Breedveld, T. J. M. Smeets, M. R. Daha, P. M. Kluin, A. E. Meinders, and R. N. Maini. 1996. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum. 39: 1077.
18. Elliott, M. J., R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Leeb, F. C. Breedveld, J. D. Macfarlene, H. Bijl, and J. N. Woody. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105.
19. Paleolog, E. M., M. Hunt, M. J. Elliott, M. Feldmann, R. N. Maini, and J. N. Woody. 1996. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor α antibody in rheumatoid arthritis. Arthritis Rheum. 39: 1082.
20. Stauber, G. B., and B. B. Aggarwal. 1989. Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (tumor necrosis factor-β) on a human histiocytic lymphoma cell line, U-937. J. Biol. Chem. 264: 3573.
21. Aggarwal, B. B., T. E. Eessalu, and P. E. Hass. 1985. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 318:665.
22. Brockhaus, M., H.-J. Schoenfeld, E.-J. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87:3127.
23. Eugster, H.-P., M. Muller, U. Karrer, B. D. Car, B. Schnyder, V. M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Aguet, R. Zinkernagel, H. Bluethmann, and B. Ryffel. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int. Immunol. 8:23.
24. Körner, H., M. Cook, D. S. Riminton, F. A. Lemckert, R. M. Hoek, B. Ledermann, F. Köntgen, B. Fazekas de St. Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27:2600.
25. Mancini, G., A. O. Carbonara, and J. F. Heremans. 1965. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235.
26. Lissner, C. R., R. N. Swanson, and A. D. O'Brien. 1983. Genetic control of the innate resistance of mice to Salmonella Typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J. Immunol. 131:3006.
27. Wiedermann, U., A. Tarkowski, T. Bremell, L. Å. Hanson, H. Kahu, and U. I. Dahlgren. 1996. Vitamin A deficiency predisposes to Staphylococcus aureus infection. Infect. Immun. 64:1.
28. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
29. Brennan, F. M., D. Chantry, A. Jackson, R. Maini, and M. Feldmann. 1989. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244.
30. Hawoth, C., F. M. Brennan, D. Chantry, M. Turner, R. N. Maini, and M. Feldmann. 1991. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α. Eur. J. Immunol. 21:2575.
31. Butler, D., R. N. Maini, M. Feldmann, and F. M. Brennan. 1995. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures with an anti TNFα monoclonal: comparison with blockade of IL-1 using the recombinant IL-1 receptor antagonist. Eur. Cytokine Netw. 6:225.
32. Mackay, F., H. Loetscher, D. Steuber, G. Gehr, and W. Lesslauer. 1993. Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177: 1277.
33. Slowik, M. R., L. O. De Luca, W. Fiers, and J. S. Pober. 1993. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am. J. Pathol. 143:1724.
34. Körner, H., D. S. Riminton, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1997. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation denned by gene targeting. J. Exp. Med. 186:1585.
35. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
36. Horowitz, M. C. 1993. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260:626.
37. Nakane, A., M. Okamoto, M. Asano, M. Kohanawa, and T. Minigawa. 1995. Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect. Immun. 63:1165.
38. Ryffel, B., F. Di Padova, M. H. Schreier, M. Le Hir, H.-P. Eugster, and V. F. J. Quesniaux. 1997. Lack of type 2 T cell-indepependent B cell responses and defect in isotype switching in TNF-lymphotoxin α-deficient mice. J. Immunol. 158:2126.
39. Müller, M., H.-P. Eugster, M. Le Hir, A. Shakhov, F. Di Padova, C. Maurer, V. F. J. Quesniaux, and B. Ryffel. 1996. Correction of the TNF/LTα deficient phenotype by bone marrow transplantation. Mol. Med. 2:247.
40. Nossal, G. J., A. Abbot, J. Mitchell, and Z. Lummus. 1968. Antigens in immunity. XV. Ultrastructural features of antigen capture in primary and secondary lymphoid follicles. J. Exp. Med. 127:277.
41. Tew, J. G., M. H. Kosco, G. F. Burton, and A. K. Szakal. 1990. Follicular dendritic cells as accessory cells. Immunol. Rev. 117:185.
42. Gray, D., and H. Skarvall. 1988. B-cell memory is short-lived in the absence of antigen. Nature 336:70.
43. Klauss, G. G., J. H. Humphrey, A. Kunkl, and D. W. Dongworth. 1980. The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol. Rev. 53:3.
44. Le Hir, M., H. Bluethmann, M. H. Kosco-Vilbois, M. Müller, F. di Padova, M. Moore, B. Ryffel, and H.-P. Eugster. 1996. Differntiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J. Exp. Med. 183:2367.
45. Browning, J. L., M. J. Androlewicz, and C. F. Ware. 1991. Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma. J. Immunol. 147:1230.
46. Ware, C. F., P. D. Crowe, M. H. Grayson, M. J. Androlewicz, and J. L. Browning. 1992. Expression of surface lymphotoxin and tumor necrosis factor on activated T. B. and natural killer cells. J. Immunol. 149:3881.
47. Browning, J. L., A. Ngam-ek, P. Lawton, J. DeMarinis, R. Tizard, E. P. Chow, C. Hession, B. O'Brine-Greco, S. F. Foley, and C. F. Ware. 1993. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex complex with lymphotoxin on the cell surface. Cell 72:847.
48. Androlewicz, M. J., J. L. Browning, and C. F. Ware. 1992. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J. of Biol. Chem. 267:2542.
49. Crowe, P. D., T. L. VanArsdale, W. B. N., C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-β-specific receptor. Science 264:707.
50. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. Kuklin, D. M. Bouley, J. Thomas, S. Kanangat, and M. L. Mucenski. 1995. Lymphotoxin-α-deficient mice. J. Immunol. 155:1685.
51. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. S. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, J. H. Russell, R. Karr, and D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.
52. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093.
53. Fischer, C. J., Jr., J. M. Agosti, S. M. Opal, S. F. Lowry, R. A. Balk, J. C. Sadoff, E. Abraham, R. M. H. Schein, and E. Benjamin. 1996. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N. Engl. J. Med. 334: 1697.
54. Trueb, R., G. Brown, C. Van Huffel, A. Poltorak, M. Valdez-Silva, and B. Beutler. 1995. Expression of an adenovirally encoded lymphotoxin-β inhibitor prevents clearance of Listeria monocytogenes in mice. J. Inflamm. 45:239.